Compare SpaceX (SPCX) vs 22nd Century Group Inc (XXII) Price & Performance

SPCX trades at $119.85, down 3.34% over 24 hours amid volatile post-IPO performance. The stock shows mixed technical signals with bearish moving averages but bullish oscillators. Fundamentally, the company reported a net loss of $4.94B on $18.67B revenue in 2025, with negative margins and elevated valuation ratios. Recent news highlights upcoming earnings on August 4, 2026, and a significant share unlock event, contributing to heightened investor attention and short interest.

Despite current losses, analyst consensus remains strongly bullish with a $237.78 price target, citing long-term AI infrastructure potential. Key risks include high short interest, lock-up expirations, and execution challenges in scaling profitability. The stock presents a high-risk, high-reward opportunity dependent on future earnings improvements and market sentiment shifts.

XXII trades at $4.32, down 0.23% on the day, with neutral technical signals and bearish moving averages. The company shows significant financial challenges with negative profit margins (-65.76% net income margin) and declining revenue, though analyst sentiment remains positive with 75% buy ratings. Recent corporate actions include a 20:1 reverse stock split completed in June 2026, while expansion initiatives in California and New York aim to drive VLN brand growth.

The outlook remains speculative with high execution risk given persistent losses and negative ROE (-130.19%). Investment opportunity hinges on successful commercialization of reduced-nicotine products and FDA regulatory progress, but substantial financial deterioration and competitive pressures present significant downside risk for shareholders.